Novel 1,3,5-triphenyl-2-pyrazolines as anti-infective agents

Bioorganic and Medicinal Chemistry Letters

Volumn 20, Issue 10, 2010, Pages 3169-3172

  Sivakumar, P M ^a   Prabhu Seenivasan, S ^b   Kumar, Vanaja ^b   Doble, Mukesh ^a  

^a INDIAN INSTITUTE OF TECHNOLOGY MADRAS   (India)

^b NATIONAL INSTITUTE FOR RESEARCH IN TUBERCULOSIS   (India)

Author keywords

1,3,5 Triphenyl 2 pyrazolines; Alog P; High resolution mass spectrum (HR MS); Mycobacterium tuberculosis H37Rv

Indexed keywords

1,3,5 TRIPHENYL 2 PYRAZOLINE DERIVATIVE; ANTIINFECTIVE AGENT; GLYCOPROTEIN P; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIFUNGAL ACTIVITY; ARTICLE; ASPERGILLUS FLAVUS; ASPERGILLUS NIGER; BACILLUS SUBTILIS; CANDIDA TROPICALIS; CHEMICAL MODIFICATION; CONTROLLED STUDY; DRUG STRUCTURE; DRUG SYNTHESIS; ENTEROBACTER AEROGENES; ESCHERICHIA COLI; FUSARIUM PROLIFERATUM; HYDROPHILICITY; IN VITRO STUDY; INFRARED SPECTROSCOPY; LIPOPHILICITY; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PROTEUS VULGARIS; SALMONELLA TYPHI; STAPHYLOCOCCUS AUREUS; STRUCTURE ACTIVITY RELATION;

ANTI-INFECTIVE AGENTS; ESCHERICHIA COLI; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM TUBERCULOSIS; P-GLYCOPROTEIN; PYRAZOLES; STAPHYLOCOCCUS AUREUS;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; FUNGI; MYCOBACTERIUM TUBERCULOSIS; STAPHYLOCOCCUS AUREUS;

EID: 77952323445     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2010.03.083     Document Type: Article

References (24)

1. Madison B.M. Biotech. Histochem. 76 (2001) 119
2. Mativandlela S.P.N., Lall N., and Meyer J.J.M. S. Afr. J. Bot. 72 (2006) 232
3. Malmvall B.E., Molstad S., Darelid J., Hiselius A., Larsson L., Swanberg J., and Abom P.E. Qual. Manag. Health Care 16 (2007) 60
4. Frosco M., and Barrett J.F. Expert Opin. Invest. Drugs 7 (1998) 175
5. Moellering R.C., Graybill J.R., McGowan Jr. J.R., and Corey L. Am. J. Infect. Control 35 (2007) S1
6. Marquez B. Biochimie 87 (2005) 1137
7. Karthikeyan M.S., Holla B.S., and Kumari N.S. Eur. J. Med. Chem. 42 (2007) 30
8. Padmavathi V., Thriveni P., Reddy G.S., and Deepti D. Eur. J. Med. Chem. 43 (2008) 917
9. Chimenti F., Bizzarri B., Manna F., Bolasco A., Secci D., Chimenti P., Granese A., Rivanera D., Lilli D., Scaltrito M.M., and Brenciaglia M.I. Bioorg. Med. Chem. Lett. 15 (2005) 603
10. Ali M.A., Shaharyar M., and Siddiqui A.A. Eur. J. Med. Chem. 42 (2007) 268
11. Shaharyar M., Siddiqui A.A., Ali M.A., Sriram D., and Yogeeswari P. Bioorg. Med. Chem. Lett. 16 (2006) 3947
12. Manna F., Chimenti F., Fioravanti R., Bolasco A., Secci D., Chimenti P., Ferlini C., and Scambia G. Bioorg. Med. Chem. Lett. 15 (2005) 4632
13. Sivakumar P.M., Seenivasan S.P., Kumar V., and Doble M. Bioorg. Med. Chem. Lett. 17 (2007) 1695
14. Sivakumar P.M., Priya S., and Doble M. Chem. Biol. Drug Des. 73 (2009) 403
15. Sarker S.D., Nahar L., and Kumarasamy Y. Methods 42 (2007) 321
16. Kumar K.A., Singh S.K., Kumar B.S., and Doble M. CEJC 5 (2007) 880
17. 2SCl: calcd = 379.1036, found = 379.1040.
18. Oh C., Lee C., Lee J., and Cho J. Arch. Pharm. Pharm. Med. Chem. 336 (2003) 504
19. Ragno R., Marshall G.R., Santo R.D., Costi R., Massa S., Rompei R., and Artico M. Bioorg. Med. Chem. 8 (2000) 1423
20. Matyk J., Waisser K., Drazkova K., Kunes J., Klimesova V., Palat K.J., and Kaustova J. IL Farmaco 60 (2005) 399
21. Klimesova V., Palat K., Waisser K., and Klimes J. Int. J. Pharm. 207 (2000) 1
22. Ansari F.L., Baseer M., Iftikhar F., Kulsoom S., Ullah A., Nazir S., Shaukat A., Haq I., and Mirza B. ARKIVOC x (2009) 318
23. Sivakumar P.M., Sheshayan G., and Doble M. Chem. Biol. Drug Des. 72 (2008) 303
24. Sivakumar P.M., Geetha Babu S.K., and Doble M. Chem. Biol. Drug Des. 71 (2008) 447